BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 26071203)

  • 21. Alpha-actinin is a cross-reactive renal target for pathogenic anti-DNA antibodies.
    Deocharan B; Qing X; Lichauco J; Putterman C
    J Immunol; 2002 Mar; 168(6):3072-8. PubMed ID: 11884481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between the presence of anti-C1q antibodies and active nephritis in patients with systemic lupus erythematosus.
    Gargiulo Mde L; Gómez G; Khoury M; Collado MV; Suárez L; Álvarez C; Sarano J
    Medicina (B Aires); 2015; 75(1):23-8. PubMed ID: 25637896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum IgG2 antibody multi-composition in systemic lupus erythematosus and in lupus nephritis (Part 2): prospective study.
    Bruschi M; Moroni G; Sinico RA; Franceschini F; Fredi M; Vaglio A; Cavagna L; Petretto A; Pratesi F; Migliorini P; Locatelli F; Pazzola G; Pesce G; Bagnasco M; Manfredi A; Ramirez GA; Esposito P; Murdaca G; Negrini S; Cipriani L; Trezzi B; Emmi G; Cavazzana I; Binda V; d'Alessandro M; Fenaroli P; Pisani I; Garibotto G; Montecucco C; Santoro D; Scolari F; Volpi S; Mosca M; Tincani A; Candiano G; Prunotto M; Verrina E; Angeletti A; Ravelli A; Ghiggeri GM
    Rheumatology (Oxford); 2021 Jul; 60(7):3388-3397. PubMed ID: 33351137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of Autoantibodies to Erythropoietin Receptor in Systemic Lupus Erythematosus with Biopsy-proven Lupus Nephritis.
    Hara A; Furuichi K; Yamahana J; Yasuda H; Iwata Y; Sakai N; Shimizu M; Kaneko S; Wada T
    J Rheumatol; 2016 Jul; 43(7):1328-34. PubMed ID: 27134248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-heparan sulfate antibody and functional loss of glomerular heparan sulfate proteoglycans in lupus nephritis.
    Kim HJ; Hong YH; Kim YJ; Kim HS; Park JW; Do JY; Kim KJ; Bae SW; Kim CW; Lee CK
    Lupus; 2017 Jul; 26(8):815-824. PubMed ID: 28420046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mesangial cell-binding anti-DNA antibodies in patients with systemic lupus erythematosus.
    Chan TM; Leung JK; Ho SK; Yung S
    J Am Soc Nephrol; 2002 May; 13(5):1219-29. PubMed ID: 11961009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunological aspects of biopsy-proven lupus nephritis in Bahraini patients with systemic lupus erythematosus.
    Farid EM; Hassan AB; Abalkhail AA; El-Agroudy AE; Arrayed SA; Al-Ghareeb SM
    Saudi J Kidney Dis Transpl; 2013 Nov; 24(6):1271-9. PubMed ID: 24231503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum level of proximal renal tubular epithelial cell-binding immunoglobulin G in patients with lupus nephritis.
    Yap DY; Yung S; Zhang Q; Tang C; Chan TM
    Lupus; 2016 Jan; 25(1):46-53. PubMed ID: 26251400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-neutrophil cytoplasmic antibodies (ANCA) in systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies.
    Pradhan VD; Badakere SS; Bichile LS; Almeida AF
    J Assoc Physicians India; 2004 Jul; 52():533-7. PubMed ID: 15645975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mesangial cell-specific antibodies are central to the pathogenesis of lupus nephritis.
    Seret G; Le Meur Y; Renaudineau Y; Youinou P
    Clin Dev Immunol; 2012; 2012():579670. PubMed ID: 22162716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-nucleosome antibodies as a disease marker in systemic lupus erythematosus and its correlation with disease activity and other autoantibodies.
    Pradhan VD; Patwardhan MM; Ghosh K
    Indian J Dermatol Venereol Leprol; 2010; 76(2):145-9. PubMed ID: 20228543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Absence of Anti-Glomerular Basement Membrane Antibodies in 200 Patients With Systemic Lupus Erythematosus With or Without Lupus Nephritis: Results of the GOODLUPUS Study.
    Bourse Chalvon N; Orquevaux P; Giusti D; Gatouillat G; Tabary T; Tonye Libyh M; Chrusciel J; Drame M; Stockton-Bliard G; Amoura Z; Arnaud L; Lorenz HM; Blaison G; Bonnotte B; Magy-Bertrand N; Revuz S; Voll RE; Hinschberger O; Schwarting A; Pham BN; Martin T; Pennaforte JL; Servettaz A
    Front Immunol; 2020; 11():597863. PubMed ID: 33381119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of anti-alpha-actinin antibodies in the pathogenesis and monitoring of lupus nephritis.
    Youinou P; Putterman C
    Arthritis Res Ther; 2009; 11(6):137. PubMed ID: 20017900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiphospholipid Antibodies in Lupus Nephritis.
    Parodis I; Arnaud L; Gerhardsson J; Zickert A; Sundelin B; Malmström V; Svenungsson E; Gunnarsson I
    PLoS One; 2016; 11(6):e0158076. PubMed ID: 27336701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autoantibodies targeting glomerular annexin A2 identify patients with proliferative lupus nephritis.
    Caster DJ; Korte EA; Merchant ML; Klein JB; Wilkey DW; Rovin BH; Birmingham DJ; Harley JB; Cobb BL; Namjou B; McLeish KR; Powell DW
    Proteomics Clin Appl; 2015 Dec; 9(11-12):1012-20. PubMed ID: 25824007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Anti-mesangial cell autoantibodies and their target antigens in lupus nephritis].
    Chen M; Wang YY; Zhao MH
    Zhonghua Nei Ke Za Zhi; 2003 Dec; 42(12):851-3. PubMed ID: 14728876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-C1q autoantibodies in lupus nephritis: prevalence and clinical significance.
    Sinico RA; Radice A; Ikehata M; Giammarresi G; Corace C; Arrigo G; Bollini B; Li Vecchi M
    Ann N Y Acad Sci; 2005 Jun; 1050():193-200. PubMed ID: 16014534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoantibodies in lupus nephritis patients requiring renal transplantation.
    Stinton LM; Barr SG; Tibbles LA; Yilmaz S; Sar A; Benedikttson H; Fritzler MJ
    Lupus; 2007; 16(6):394-400. PubMed ID: 17664229
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased IgG on cell-derived plasma microparticles in systemic lupus erythematosus is associated with autoantibodies and complement activation.
    Nielsen CT; Østergaard O; Stener L; Iversen LV; Truedsson L; Gullstrand B; Jacobsen S; Heegaard NH
    Arthritis Rheum; 2012 Apr; 64(4):1227-36. PubMed ID: 22238051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus.
    Amoura Z; Koutouzov S; Chabre H; Cacoub P; Amoura I; Musset L; Bach JF; Piette JC
    Arthritis Rheum; 2000 Jan; 43(1):76-84. PubMed ID: 10643702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.